CNN – This was announced by the drug manufacturer Eli Lilly Tuesday that its flagship weight loss drug, Zepbound, is now available for patient use. Tirzepatide, its active ingredient, was approved by the US Food and Drug Administration to treat type 2 diabetes called Mounjaro. Last month, the FDA approved it for use in chronic … [Read more…]
An Eli Lilly and Company pharmaceutical manufacturing facility is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Portal/Mike Segar/File Photo Acquire License Rights Dec 5 (Portal) – Eli Lilly (LLY.N) said on Tuesday that its recently approved obesity treatment, Zepbound, is now available in U.S. pharmacies and will cost $550 for … [Read more…]
Pfizer’s twice-daily version of its experimental weight-loss pill now joins a long list of other eliminated obesity drugs. Pfizer’s move to scrap two obesity drug candidates last year shows how difficult it is to develop an effective, safe and tolerable weight loss treatment. Before successful weight-loss treatments like Wegovy and Ozempic, the path to treating … [Read more…]
CNN – Overweight and obese adults who took the injected drug Mounjaro lost more weight and were more likely to reach certain weight-loss goals than people who took a similar competing product, Ozempic, according to a new study of people who took the drugs in the real world. Both Ozempic, or semaglutide, and Mounjaro, or … [Read more…]
Shutting down a passenger aircraft’s engines in mid-air is not a recommended procedure in a flight manual. But Alaska Airlines pilot Joseph Emerson certainly wasn’t following the rules. The 44-year-old father of two was off duty but caught a ride – as pilots often do – in the cockpit of an Alaska flight from Washington … [Read more…]